Please Wait
Applying Filters...
menu
    • menu
    Fermion-PSE
    News
    Orion Announces Improved Financial Outlook For Coming Year

    15 Jan 2025

    // PRESS RELEASE

    Orion Committee Prepares Proposals For Annual Meeting Agenda

    15 Jan 2025

    // PRESS RELEASE

    Orion’s partner Bayer in China for 3rd indication of darolutamide

    08 Jan 2025

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Fermion

    Contact Supplier

    Website

    PharmaVenue

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/NUY-WJrSlVU
    Menu

    Orion Corporation

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Orion Announces Improved Financial Outlook For Coming Year
    Orion Announces Improved Financial Outlook For Coming Year

    15 Jan 2025

    // PRESS RELEASE

    https://www.orion.fi/en/newsroom/all-news/releases/stock-releases/2024/inside-information-orion-upgrades-full-year-outlook-for-2024/

    PRESS RELEASE
    15 Jan 2025
    Share Share
    Orion Committee Prepares Proposals For Annual Meeting Agenda
    Orion Committee Prepares Proposals For Annual Meeting Agenda

    15 Jan 2025

    // PRESS RELEASE

    https://www.orion.fi/en/newsroom/all-news/releases/stock-releases/2025/recommendation-by-the-orion-nomination-committee-on-the-proposals-to-be-submitted-to-the-2025-annual-general-meeting/

    PRESS RELEASE
    15 Jan 2025
    Share Share
    Orion’s partner Bayer in China for 3rd indication of darolutamide
    Orion’s partner Bayer in China for 3rd indication of darolutamide

    08 Jan 2025

    // PRESS RELEASE

    https://www.orion.fi/en/newsroom/all-news/releases/press-releases/2025/orions-collaboration-partner-bayer-submits-application-in-china-for-third-indication-of-darolutamide/

    PRESS RELEASE
    08 Jan 2025
    Share Share
    Orion and Marinus terminate agreement for ganaxolone in Europe
    Orion and Marinus terminate agreement for ganaxolone in Europe

    02 Jan 2025

    // PRESS RELEASE

    https://www.orion.fi/en/newsroom/all-news/releases/press-releases/2024/orion-and-marinus-terminate-agreement-for-ganaxolone-in-europe/

    PRESS RELEASE
    02 Jan 2025
    Share Share
    Orion and Marinus terminate agreement for ganaxolone in Europe
    Orion and Marinus terminate agreement for ganaxolone in Europe

    30 Dec 2024

    // #N/A

    https://www.orion.fi/en/newsroom/all-news/releases/press-releases/2024/orion-and-marinus-terminate-agreement-for-ganaxolone-in-europe/

    #N/A
    30 Dec 2024
    Share Share
    Abilita and Orion Announce Research Collab to Next-Gen Antibody
    Abilita and Orion Announce Research Collab to Next-Gen Antibody

    19 Dec 2024

    // PRESS RELEASE

    https://www.orion.fi/en/newsroom/all-news/releases/press-releases/2024/orion-and-abilita-therapeutics-announce-research-collaboration-and-option-to-license-agreement-to-develop-innovative-antibody-therapeutics/

    PRESS RELEASE
    19 Dec 2024
    Share Share